Physician profile
Laura Farber
NPI 1760828636
$1,206.54
in general payments reported to CMS, 2019-2025
16 companies · $279 in 2025
The $279 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.93 · 2021: $76.02 · 2022: $300 · 2023: $176 · 2024: $296 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $751.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $153.89 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $147.69 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sun Pharmaceutical Industries INC. | $143.76 | 2022-2024 | |
| Sight Sciences, INC. | $124.24 | 2022 | |
| Abiomed | $100.77 | 2023 | Impella |
| Bausch & Lomb Americas INC. | $86.43 | 2025 | Xiidra, Miebo |
| Johnson & Johnson Surgical Vision, INC. | $73.76 | 2019-2023 | Tecnis Iol, Tecnis Iol |
| Abbvie INC. | $69.06 | 2022-2023 | |
| Dompe US, INC. | $67.66 | 2019-2025 | Oxervate |
| Potrero Medical, INC. | $66.88 | 2022 | |
| Allergan, INC. | $54.07 | 2021-2022 | |
| Alcon Vision LLC | $31.07 | 2021-2024 | Precision 1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $29.48 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $23.03 | 2024 | Xdemvy |
| Rayner Intraocular Lenses Limited | $17.79 | 2025 | Omidria |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Quidel Corporation | $16.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Farber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.